Evaluate teams up with Treehill Partners
Evaluate, a London-based market data and research consultancy focusing on the life sciences industry, has entered a strategic collaboration with Treehill Partners, a New York-based strategic and financial advisory firm specializing in healthcare industry transactions.
The collaboration will meld the data analytics expertise of Evaluate with the transaction advisory and execution expertise of Treehill Partners.
“This alliance demonstrates our strong commitment to our clients, providing them with enhanced services in areas where we are seeing increasing demand, notably transactions related advisory,” said Cem Baydar, chief consulting officer at Evaluate. “The combination of our proprietary data analytics platform and our strategic consulting services with the transaction advisory and execution capabilities of Treehill will bring tremendous value to our clients.”
Treehill was founded in 2014 and has a team of approximately five professionals, according to LinkedIn. The firm is led by partner and co-founder Ali Pashazadeh, who previously headed Blackstone’s healthcare advisory team and UBS’ European biotech coverage.
Treehill supports clients in the healthcare industry throughout the deal lifecycle, from buy-side acquisition and investment to sell-side disposal and divestment.
“This collaboration represents a unique value proposition in the marketplace as it brings our transaction perspective and execution capability into Evaluate’s strategic healthcare consulting practice, providing our shared clients with a uniquely differentiated solution to their situational strategic and transaction needs,” Pashazadeh said.
Evaluate was founded in 1996 and provides proprietary and industry data and intelligence to help pharma clients make better-informed decisions on high-value investments in treatments and markets. The firm also provides strategic consulting across corporate strategy, market expansion, new product development, pricing, and commercialization.
Evaluate has more than 200 employees across offices in London, Boston, and Tokyo, according to LinkedIn.